SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Future Horizons and Growth Strategies in the US Cancer Diagnostics Market 2014: Supplier Shares and Country Forecasts

[September 04, 2014]

Research and Markets: Future Horizons and Growth Strategies in the US Cancer Diagnostics Market 2014: Supplier Shares and Country Forecasts

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/927bkd/future_horizons) has announced the addition of the "Future Horizons and Growth Strategies in the US Cancer Diagnostics Market 2014: Supplier Shares and Country Forecasts" report to their offering.

2014 Opportunities in the US Cancer Diagnostics Market is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the French cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

The cancer diagnostics market is on the verge of exposion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.


Cancer Diagnostic Tests - Over 200 current and emerging assays including:

ACTH, AFP, Beta-2 Microglobulin, CA (News - Alert) 15-3/27.29, CA 19-9, CA 125, Calcitonin, Cathepsin, CEA, Chromogranin, Colon-Specific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG, Insulin, Interferons, Interleukins, Lymphocyte Subtyping, Neuron-Specific Enolase, Nucleolar, Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone, Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S-100 Protein, Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin, Tissue Polypeptide Antigen, and others.

Market Segmentation Analysis

  • Sales and market shares of major suppliers, by individual cancer diagnostic test.
  • Five-year test volume and sales forecasts for major cancer diagnostic tests by market segment
  • Hospitals
  • Commercial/Private Laboratories
  • Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers.
  • Cancer statistics, etiology and recent developments.

For more information visit http://www.researchandmarkets.com/research/927bkd/future_horizons


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved | Privacy Policy